Latest Breaking News On - Apellis pharmaceuticals price performance - Page 4 : comparemela.com

Teacher Retirement System of Texas Buys 1,203 Shares of Apellis Pharmaceuticals, Inc (NASDAQ:APLS)

Teacher Retirement System of Texas grew its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 5.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,099 shares of the company’s stock after purchasing an additional 1,203 shares during the quarter. […]

United statesJeffrey eiselePascal deschateletsApellis pharmaceuticals profileAmerican century companies incUs bancorpApellis pharmaceuticalsQuarter for apellis pharmaceuticalsYork mellon corpSecurities exchange commissionMetlife investment managementGoldman sachs groupNews ratings for apellis pharmaceuticals dailyApellis pharmaceuticals price performanceApellis pharmaceuticals incTeacher retirement system

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) General Counsel Sells $271,960 00 in Stock

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) General Counsel Sells $271,960 00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesDavido watsonRobertw bairdApellis pharmaceuticalsQuarter for apellis pharmaceuticalsWells fargo companyApellis pharmaceuticals incJennison associatesApellis pharmaceuticals price performanceAmerican investors coLisanti capital growthApellis pharmaceuticals company profileNeedham companyNews ratings for apellis pharmaceuticals dailyInstitutional investors weigh in on apellis pharmaceuticalsEnvestnet asset management inc

Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 2 9%

Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Down 2 9%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesCedric francoisJeffrey eiseleApellis pharmaceuticals company profilePricet rowe associates incMorgan stanleyApellis pharmaceuticalsNorges bankHedge funds weigh in on apellis pharmaceuticalsApellis pharmaceuticals price performanceSecurities exchange commissionJennison associatesGoldman sachs groupNews ratings for apellis pharmaceuticals dailyNeedham companyApellis pharmaceuticals inc

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Receives Average Rating of Moderate Buy from Brokerages

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Receives Average Rating of Moderate Buy from Brokerages
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesAlec machielsCaroline baumalInsider transactions at apellis pharmaceuticalsApellis pharmaceuticals company profileApellis pharmaceuticalsStephens consultingApellis pharmaceuticals incNational bankInstitutional trading of apellis pharmaceuticalsNeedham companyCovestor ltdApellis pharmaceuticals price performanceFirst horizon advisors incWells fargo companyWealth management inc

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Given Average Rating of Moderate Buy by Brokerages

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen research firms that are presently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, ten have issued a buy recommendation and one has issued a strong […]

United statesPascal deschateletsRaymond jamesAlec machielsPrincipal financial group incApellis pharmaceuticals price performanceApellis pharmaceuticalsWells fargo companyWealth groupEnvestnet asset management incInstitutional investors weigh in on apellis pharmaceuticalsAnalyst recommendations for apellis pharmaceuticalsCalifornia public employees retirement systemNews ratings for apellis pharmaceuticals dailyAffinity asset advisorsApellis pharmaceuticals inc